TMA Warns TMB About Stem Cell Rules

A proposed Texas Medical Board (TMB) rule regulating the use of investigational agents, including stem cells, in treating patients might unintentionally restrict some currently accepted clinical practices, TMA President C. Bruce Malone, MD, warned in a letter to the board.

"We need to make sure current, well-established stem cell therapies, such as ordinary bone marrow transplants, do not require physicians to undertake a review and approval process by an institutional review board," Dr. Malone wrote in a formal TMA comment letter to TMB. "Bone marrow, peripheral blood stem cells, and cord blood are all used in transplants for hematopoietic reconstitution (usually referred to generically as bone marrow transplants)."

Action, Nov. 1, 2011